TB
GILD icon

Terril Brothers’s Gilead Sciences GILD Stock Holding History

Terril Brothers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,376
Closed -$600K – 52
2017
Q4 		$600K Sell
8,376
-400
-5% -$30.4K 0.18% 37
2017
Q3 		$711K Sell
8,776
-100
-1% -$7.65K 0.23% 30
2017
Q2 		$628K Sell
8,876
-81
-0.9% -$5.39K 0.22% 30
2017
Q1 		$608K Buy
8,957
+31
+0.3% +$2.18K 0.21% 30
2016
Q4 		$639K Buy
8,926
+126
+1% +$9.37K 0.22% 31
2016
Q3 		$696K Buy
+8,800
New +$715K 0.37% 26

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Terril Brothers's GILD Position: Q1 2018 in Review

Terril Brothers sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 8,376 shares — an estimated $600K sold.

Terril Brothers first reported a position in GILD in Q3 2016 and held it in 6 quarters. The position peaked at $711K in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Terril Brothers reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Terril Brothers sold 8,376 Gilead Sciences shares in Q1 2018, an estimated $600K.
  • Terril Brothers first reported a position in Gilead Sciences in Q3 2016 and held it in 6 quarters.
  • Terril Brothers's Gilead Sciences position peaked at $711K in Q3 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Terril Brothers's 13F filing for Q1 2018, filed 3 May 2018.